Conduction Disorders: The Achilles' Heel of TAVR?

Antonin Fournier1, Pierre Robert2, Jean-Christophe Macia1

  • 1Department of Cardiology, CHU Montpellier, Arnaud de Villeneuve Hospital, University of Montpellier, Avenue du doyen Giraud, 34295 Montpellier, France.

PubMed

Insights

High degree conductive disorders after TAVR, a complication requiring permanent pacemaker implantation, are reviewed. This analysis focuses on predicting and managing these events to optimize patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • High-degree conductive disorders (CD) requiring permanent pacemaker implantation (PPI) are significant complications following transcatheter aortic valve replacement (TAVR).
  • Current management strategies for post-TAVR CD remain controversial, highlighting a need for clearer guidelines.

Purpose of the Study:

  • To review the mechanisms and risk factors associated with CD after TAVR.
  • To evaluate the role of electrocardiogram (ECG) and multi-slice computed tomography (MSCT) in assessing anatomical parameters for CD risk.
  • To summarize strategies for anticipating, detecting, and managing high-degree CD and optimizing PPI indications post-TAVR.

Main Methods:

  • Narrative review of existing literature.
  • Literature search using keywords: conductive disorders, TAVR, and pacemaker implantation.
  • Focus on ECG evaluation, anatomical parameters from MSCT, and procedural aspects.

Main Results:

  • Conductive disorders requiring permanent pacemaker implantation are a primary complication of TAVR.
  • A comprehensive evaluation integrating ECG, MSCT-derived anatomical data, and procedural factors is crucial for risk assessment.
  • Optimizing PPI indications and exploring novel monitoring and pacing techniques are essential for improved patient care.

Conclusions:

  • There is a need for improved strategies to anticipate and detect high-degree CD after TAVR to reduce incidence.
  • Clearer recommendations for PPI indications are required to optimize outcomes for patients undergoing TAVR.
  • Future perspectives include ambulatory monitoring, machine learning, and advanced pacing techniques for managing post-TAVR CD.